|
|
Volumn 11, Issue 7, 2012, Pages 567-
|
|
Colombia at the centre of preclinical AD research
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID PRECURSOR PROTEIN;
CRENEZUMAB;
PRESENILIN 1;
PRESENILIN 2;
ALZHEIMER DISEASE;
CLINICAL RESEARCH;
COGNITIVE DEFECT;
COLOMBIA;
EDITORIAL;
GENE MUTATION;
HETEROZYGOTE;
HUMAN;
MEMORY DISORDER;
ONSET AGE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ALZHEIMER DISEASE;
ANTIBODIES, MONOCLONAL;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS AS TOPIC;
COLOMBIA;
HUMANS;
PRESENILINS;
|
|
EID: 84873072617
PISSN: 14744422
EISSN: 14744465
Source Type: Journal
DOI: 10.1016/S1474-4422(12)70144-8 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|